Literature DB >> 12677602

Congenital extrahepatic portocaval shunt (Abernethy type 2), huge liver mass, and patent ductus arteriosus--a case report of its rare clinical presentation in a young girl.

Yutaka Kanamori1, Kohei Hashizume, Yoshihiro Kitano, Masahiko Sugiyama, Toru Motoi, Tsuyoshi Tange.   

Abstract

The authors report a case of congenital extrahepatic portocaval shunt with a hypoplastic portal vein. This type of shunt is called an Abernethy type 2 shunt, where the portal vein and inferior vena cava are connected side to side, and a hypoplastic portal flow exists in the liver parenchyma. This case of a young girl is complicated with a cardiac anomaly and a large hyperplastic nodule in the liver. This phenotype usually is seen in the Abernethy type 1 shunt, which is a side-to-end shunt with the complete absence of a portal vein. In this context, the current case is very unique in its clinical manifestation, and this phenotype has never been reported. Therefore, it is important to speculate the etiology and treatment of this kind of abnormality and its associated hepatic mass. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12677602     DOI: 10.1053/jpsu.2003.50153

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Multiple regenerative nodular hyperplasia in the left infrarenal vena cava accompanied by Abernethy malformation.

Authors:  Zuhal Gülşen; Hasan Yiğit; Pelin Demir
Journal:  Surg Radiol Anat       Date:  2015-03-27       Impact factor: 1.246

2.  Abernethy malformation: congenital absence of the portal vein.

Authors:  Lukasz Kwapisz; Malcolm M Wells; Bandar AlJudaibi
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

3.  New type of asymptomatic congenital portosystemic shunt.

Authors:  Gabriele Bazzocchi; Daniela Pastorelli; Fabia Laviani; Giovanni Simonetti
Journal:  Clin J Gastroenterol       Date:  2008-11-15

4.  Prenatal Diagnosis and Outcome of Umbilical-Portal-Systemic Venous Shunts: Experience of a Tertiary Center and Proposal for a New Complex Type.

Authors:  Rodica Daniela Nagy; Dominic Gabriel Iliescu
Journal:  Diagnostics (Basel)       Date:  2022-03-31

Review 5.  Congenital extrahepatic portosystemic shunt: description of four cases and review of the literature.

Authors:  Francesca Romana Ponziani; Mariella Faccia; Maria Assunta Zocco; Valerio Giannelli; Adriano Pellicelli; Giuseppe Maria Ettorre; Nicoletta De Matthaeis; Fabrizio Pizzolante; Anna Maria De Gaetano; Laura Riccardi; Maurizio Pompili; Gian Ludovico Rapaccini
Journal:  J Ultrasound       Date:  2018-10-24

6.  Congenital intrahepatic portosystemic venous shunt and liver mass in a child patient: successful endovascular treatment with an amplatzer vascular plug (AVP).

Authors:  Sae Ah Lee; Young Seok Lee; Kun Song Lee; Gyeong Sik Jeon
Journal:  Korean J Radiol       Date:  2010-08-27       Impact factor: 3.500

7.  Abernethy malformation with portal vein aneurysm in a child.

Authors:  Sheragaru H Chandrashekhara; Ashu Seith Bhalla; Arun Kumar Gupta; C S Vikash; Susheel Kumar Kabra
Journal:  J Indian Assoc Pediatr Surg       Date:  2011-01

8.  [Focal nodular liver lesions associated with a congenital portocaval shunt in an adult woman].

Authors:  C Hillerer; E Schulte-Frohlinde; M Dobritz; J Gaa
Journal:  Radiologe       Date:  2007-02       Impact factor: 0.635

9.  Case report: Congenital extrahepatic portocaval shunt presenting as pulmonary arterial hypertension in a pregnant patient.

Authors:  Matevž Harlander; Maja Badovinac; Frosina Markoska; Barbara Salobir; Tomaž Štupnik; Marija Iča Dolenšek; Izidor Kern; Vojka Gorjup; Nazzareno Galiè
Journal:  Pulm Circ       Date:  2022-01-03       Impact factor: 2.886

10.  Histopathology of livers in patients with congenital portosystemic shunts (Abernethy malformation): a case series of 22 patients.

Authors:  Claudio De Vito; Athanasios Tyraskis; Mark Davenport; Richard Thompson; Nigel Heaton; Alberto Quaglia
Journal:  Virchows Arch       Date:  2018-10-24       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.